Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B26f9190b5f4fd5a9b9f2dc32cd248fa7> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B26f9190b5f4fd5a9b9f2dc32cd248fa7 NCIT_P378 "NCI" @default.
- B26f9190b5f4fd5a9b9f2dc32cd248fa7 type Axiom @default.
- B26f9190b5f4fd5a9b9f2dc32cd248fa7 annotatedProperty IAO_0000115 @default.
- B26f9190b5f4fd5a9b9f2dc32cd248fa7 annotatedSource NCIT_C183544 @default.
- B26f9190b5f4fd5a9b9f2dc32cd248fa7 annotatedTarget "A preparation of T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting human kallikrein-2 (hK2; KLK2) expressed on tumor cells, with potential immunostimulating and antineoplastic activities. Upon administration, anti-KLK2 CAR-T cells JNJ-75229414 target and bind to KLK2-expressing tumor cells, thereby inducing selective toxicity in KLK2-expressing tumor cells. KLK2 is overexpressed in certain tumors, including prostate adenocarcinoma." @default.